"Family Connections" for Caregivers of People With Eating Disorders and Personality Disorders. (FC-ED&PD)

May 31, 2022 updated by: University of Valencia

"Family Connections" an Intervention for Caregivers of People With Eating Disorders and Personality Disorders: Study Protocol for a Randomized Controlled Trial.

The aim of our study is to verify the efficacy of the Family Connections intervention for relatives of people diagnosed with eating disorders and personality disorders in a randomized control trial with a Spanish participants.

Study Overview

Detailed Description

Eating disorders (EDs) are serious mental health problems that cause disturbances related to food intake and lead to major concerns about weight and body shape. In addition, they have an impact on social functioning and lead to psychological symptoms such as depression and anxiety, social isolation, interpersonal difficulties, low self-esteem, and reduced autonomy. These disorders share a high comorbidity with personality disorders (PD) that ranges from 27-93%, leading to increased severity and worse quality of life. Families of people with ED perceive a high burden of the illness and report mental health problems. Existing intervention programs specifically targeting caregivers of people with ED are based on psychoeducation, systemic cognitive-behavioral therapy, although specific treatments for family members of people with ED and PD are still scarce. However, a skills training program called "Family Connections" (FC) was developed by Hoffman and Fruzzetti's group for borderline personality disorder (BPD). It is a program consisting of 12 two-hour sessions that take place weekly. It is divided into six modules that include psychoeducation about the disorder and how it affects family functioning, and skills adapted from Dialectical Behavior Therapy, such as mindfulness, emotional regulation, validation, radical acceptance, and problem management, among others. In addition, all the modules include specific practical exercises, video examples, and homework. There is also a forum where family members build an emotional support network. So far, the results of this program in non-randomized clinical trials show significant decreases in the subjective experience of burden of illness, perceived distress, and depression, as well as improvements in coping strategies. The aims of this study are the following: (a) to adapt and test, in the Spanish population, the modules of the FC intervention protocol, designed to be applied specifically to relatives of patients with ED and PD; (b) to test the efficacy of FC in reducing the perceived burden of illness and clinical symptomatology in relatives of patients with ED and PD and improving family relationships and quality of life; (c) to test its efficiency, understood as the acceptance of the intervention program by the participants and clinicians, and demonstrate its viability; (d) to carry out an effective dissemination of this protocol. This paper presents the study protocol. The study design consists of a two-arm randomized controlled trial with two conditions: Family Connections (FC-ED & PD) or Treatment as usual optimized (TAU-O). Participants will be family members of patients with eating disorders and personality disorders (or dysfunctional personality traits) according to the 5th version of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The caregivers' primary outcome measures will be the BAS and a Family-Patient Critical Incident Record. Secondary outcomes will be the EDSIS, FAD-GD, MEMs, MQLI, DASS-21, DERS, and QoL. The patients' primary outcome measures will be a Family-Patient Critical Incident Record, the EAT-26, PHQ-9, OASIS, VIRS, and LEAP. Participants will be assessed at pre-treatment, post-treatment, and twelve months follow-up. The intention-to-treat principle will be used when analyzing data, using mixed-effects models with full information and maximum likelihood estimation.

Study Type

Interventional

Enrollment (Anticipated)

124

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Valencia, Spain, 46010
        • Recruiting
        • University of Valencia
        • Contact:
        • Principal Investigator:
          • Verónica Guillén, Dr
        • Principal Investigator:
          • Heliodoro Marco, Dr
        • Sub-Investigator:
          • Joaquín García-Alandete, Dr
        • Sub-Investigator:
          • Sandra Pérez, Dr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Having a family member diagnosed with eating disorders and personality disorders (or personality disorder traits).
  • Being 18 years of age or older.
  • Knowing and understanding the Spanish language.
  • Completing the informed consent.

Exclusion Criteria:

  • The presence of any pathology in the family member that keeps the intervention from being carried out (such as psychosis, schizophrenia, intellectual disability, substance dependence, etc.) will be an exclusion criterion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Family Connections for relatives of people with eating disorders and personality disorders
The intervention lasts 3 months and includes 14 two-hour sessions with a group format on a weekly basis. The FC program is divided into 7 modules: 2 of Psychoeducation (ED and PD criteria, explanatory theories, available treatments, comorbidity with PD, etc.) and 5 modules of Dialectical Behavioral Therapy skills training (Relationship mindfulness, effective communication, aceptation, validation, problem management and meaning of life).

The FC program (Fruzzetti and Hoffman, 2005) is divided into 7 modules:

  1. Introduction to the intervention program. Program objectives, guidelines, criteria, and symptoms of ED and PD.
  2. Psychoeducation on the development of ED and PD, explanatory theories, available treatments, comorbidity with PD.
  3. Emotional regulation skills and awareness, and to decrease emotional reactivity.
  4. Skills to improve the quality of relationships in family interactions (letting go of guilt and anger, acceptance skills in relationships).
  5. Communication skills and effective self-expression, such as validation.
  6. Problem management and making safe plans for crisis management.
  7. Making new sense of my relationship with my family member, an opportunity to grow together.

All the modules include practice exercises, video viewing, and homework assignment.

Active Comparator: Optimized Treatment As Usual
Family members with this condition will continue to receive the usual treatment provided by their referral care center. In addition, we will optimize the treatment, with 3 two-hour psychoeducation sessions in group format each week (ED and PD, explanatory theories, available treatments, comorbidity with PD).

Family members with this condition will continue to receive the usual treatment provided by their referral care center. In addition, we will optimize the treatment, following the recommendations of the international guidelines for the treatment of ED (NICE, 2017). There will be 3 two-hour session in group format each week, with the following components: Up-to-date information and research on ED and PD; Psychoeducation on the development of ED and PD; Explanatory theories; Available treatments and comorbidity.

In both conditions, after each face-to-face session, the participant will be asked to review the contents addressed during the session as homework (independently of the homework corresponding to the specific module being addressed). All interventions carried out with family members will be performed by clinical psychologists or general health psychologists with at least a master's degree or a doctoral degree and previous training in the application of the programs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Record of critical family-patient incidents
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Number of Binge eating and vomiting episodes (purging) in the past 3 months, Number of serious arguments between patient and caregivers in the past 3 months, Number of days of self-injury in the past 3 months, Number of episodes of verbal/physical violence with caregivers in the past 3 months; Number of visits to psychiatric emergency department in the past 3 months, Number of unscheduled therapy sessions held in the past 3 months (face-to-face, phone calls, etc.).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Burden Assessment Scale (BAS)
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
It is a 19-item scale that assesses the caregiver's objective and subjective burden due to the illness of his/her loved one within the past six months using a 4-point Likert scale ranging from 1 (nothing) to 4 (a lot). Total scores indicate that higher values mean stronger burden. The scale shows adequate validity and reliability (Cronbach's alpha ranges from .89 to .91) (Reinhard, Gubman, Horwitz & Minsky, 1994).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Eating Disorder Symptom Impact Scale (EDSIS)
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
It is a 24-item scale to assess eating disorder-specific caregiving experiences using a 5-point Likert-type scale from 0 (Never) to 4 (Nearly Always). The internal consistency is good, with Cronbach's alpha coefficients mostly above .70.
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Family Assessment Device - Global Functioning Scale
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
It is a 60-item self-report about family functioning in terms of problem-solving, communication, roles, affective responsiveness, affective involvement, behavior control, and general functioning. Items are rated on a 4-point Likert scale ranging from 1 (Completely Agree) to 4 (Strongly Disagree). The internal consistency is good (Cronbach's alphas between .72 and .83) for the subscales, with a Cronbach's alpha of .92 for general functioning.
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Mastery and Empowerment Scale (MES)
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
It is a 34-item scale divided into three domains: family, service system, and involvement in community. Items are rated on a 5-point Likert scale ranging from 1 (Completely False) to 5 (Completely True). Different studies have demonstrated that the psychometric properties of the FES are robust in both the original and translated versions (Koren et al., 1992; Singhet al., 1995; Itzhaky & Schwartz, 2001; Vuorenmaa et al., 2014).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Multicultural Quality of Life Index (MQLI)
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
The Multicultural Quality of Life Index is a culture-informed and self-rated instrument. Its 10 items cover key aspects of the concept, from physical well-being to spiritual fulfilment. Regarding its applicability, mean completion time was less than 3 minutes, and 96% of raters found it easy to use. Test-retest reliability was high (r=0.87). A Cronbach's alpha of 0.92 documented its internal consistency, and a factor analysis revealed a strong structure.
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
The Multidimensional Existential Meaning Scale (MEMS)
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
It is a 15-item scale that assesses existential meaning through three dimensions: comprehension, purpose, and mattering. Items are rated on a 7-point Likert scale ranging from 1 (Very strongly disagree) to 7 (Very strongly agree). The three MEMS subscales showed adequate internal consistency: Comprehension (ω- = 91), Purpose (ω- = 92), and Mattering (ω- = 86).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Depression, Anxiety and Stress Scale (DASS-21).
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
It is a 21-item scale in its short version that measures clinical symptoms such as depression, anxiety, and stress. Items are rated on a 4-point Likert scale ranging from 0 (It did not happen to me) to 3 (It happened to me a lot or most of the time). It shows excellent internal consistency: depression (α = .94), anxiety (α = .87), and stress (α= .91).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Difficulties in Emotion Regulation Scale (DERS)
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
In its adaptation, the authors reduced the items from 36 to 28, and they considered 5 scales instead 6. The subscales are: lack of emotional control, vital interference, lack of emotional attention, emotional confusion, and emotional rejection. Items are rated on a Likert-type scale ranging from 1 to 5 (1 = "Almost never" and 5 "Almost always"). Higher scores indicate greater difficulties with emotional regulation. Psychometric properties were adequate, with very good internal consistency (α = .93) and good test-retest reliability (pl = .74, p < .001).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opinion of treatment scale
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
This scale was designed and developed by members of the research team and constructed from an adaptation of another opinion and expectations questionnaire. The constructs this scale assesses are: opinion, acceptance and satisfaction with the skills training program, and the changes in the participants after the completion of each module. The questions refer to the rationale for the intervention, recommending the program, satisfaction with the program, usefulness, and expectations of the skills training. The items are rated on a Likert-type scale ranging from 0 "Not at all" to 10 "Very much".
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
The Eating Attitudes Test-26 (EAT-26)
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
This scale is used to evaluate the patients. It is a 26-item self-report to assess attitudes toward eating. Items are rated on a 6-point Likert scale ranging from 1 (Never) to 6 (Always). The reliability analysis indicates good internal consistency Doninger, Enders, & Burnett, 2005; Garner etal., 1982; Jorquera, et al, 2006; Nunes, Camey, Olinto, &Mari, 2005; Pereira et al., 2008).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Patient Health Questionnaire (PHQ-9)
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
This scale is used to evaluate the patients. It assesses each of the 9-DSM-IV criteria for depression in 9 items. Items are rated on a 4-point Likert scale ranging from 0 (Not at all) to 3 (Nearly Every Day).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Overall Anxiety Severity and Impairment Scale (OASIS)
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
This scale is used to evaluate the patients. It is a 5-item scale that assesses the severity and frequency of anxiety symptoms, behavioral avoidance, and the functional impairment related to anxiety. Items are rated on a 4-point Likert scale ranging from 0 to 4. The scale shows good psychometric properties such as test-retest reliability and internal consistency (α =.80).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Validating and Invalidating Responses Scale (VIRS).
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
This scale is used to evaluate the patients. It is a 16-item scale that assesses the levels of perceived validation and invalidation of caregivers' responses, divided into validating and invalidating responses. Items are rated on a 5-point Likert scale ranging from 0 (Never) to 4 (Almost Always). Higher scores signify greater perceived validation or invalidation of the responses of the caregiver being assessed.
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
Lum Emotional Availability of Parents (LEAP).
Time Frame: Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up
This scale is used to evaluate the patients. It is a 15-item questionnaire that assesses the emotional availability of mothers and fathers as perceived by the person assessing their relatives. Items are rated on a 6-point Likert scale ranging from 1 (Never) to 6 (Always). The psychometric properties are very good, such that, in a clinical sample, excellent internal consistency is observed (for the mother α = .92, and for the father α = .93). In addition, it has adequate test-retest reliability for the mother's form (r = .92) and the father's form (r = .85).
Changes will be assessed from pre-treatment to immediately after the intervention, and also at 12-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Isabel Fernández-Felipe, Universitat Jaume I de Castellón
  • Study Chair: Joaquín García-Alandete, Dr, University of Valencia
  • Study Chair: Sandra Pérez, Dr, University of Valencia
  • Study Chair: Sara Fonseca-Baeza, University of Valencia
  • Study Chair: Azucena García Palacios, Dr, Universitat Jaume I de Castellón
  • Study Chair: Rosa Baños, Dr., University of Valencia
  • Study Chair: Cristina Botella, Dr, Universitat Jaume I de Castellón

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2022

Primary Completion (Anticipated)

December 1, 2022

Study Completion (Anticipated)

December 1, 2023

Study Registration Dates

First Submitted

May 23, 2022

First Submitted That Met QC Criteria

May 31, 2022

First Posted (Actual)

June 3, 2022

Study Record Updates

Last Update Posted (Actual)

June 3, 2022

Last Update Submitted That Met QC Criteria

May 31, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Individual participant data will be available after de-identification. Supporting Information:

IPD Sharing Time Frame

The data will be available immediately after publication

IPD Sharing Access Criteria

The data will be available to anyone who wishes to access them

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Clinical Study Report (CSR)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Relatives

Clinical Trials on Family Connections for relatives of people with eating disorders and personality disorders

3
Subscribe